Company
Euphrates Vascular
The Future in Treating Distal Vessel Occlusions
Also known as EUPHRATES VASCULAR, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- St. Louis, MO, United States
- Legal name
- EUPHRATES VASCULAR, INC.
- euphratesvascular.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Euphrates Vascular is a medical device company addressing distal vascular occlusions. Our initial areas of focus include Acute Ischemic Stroke (AIS), Peripheral Artery Disease (PAD) and ST Elevated Myocardial Infarction (STEMI).
Funding snapshot
- Total raised
- $9.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $9.1M2020-07-15
Funding rounds
- Round, 2020
- $9.1M2020-07-15, SEC form D sold, 33 investors
- Round, 2018
- $590K2018-08-31, SEC form D sold, 4 investors
Products
- Hardware
- Pulse NanoMED System
Loading relationship preview